FP7Индивидуална стипендия2009–2011

HYPOTHALAMIC T3 · The role of hypothalamic thyroid hormone in the neuroendocrine regulation of appetite, energy balance and glucose homeostasis

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2009-05-01 → 2011-04-30
Финансиране от ЕС
171 868 €
Участници
1
Схема
MC-IEF

Линиите свързват координатора с партньорите.

Накратко на български

Тиреоидният хормон T3 в хипоталамуса се изследва за влиянието му върху апетита, енергийния баланс и нивата на захар в кръвта. Това помага да се разбере как мозъкът регулира метаболизма, вместо да се разчита само на действието на хормоните в тъканите.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

The role of hypothalamic thyroid hormone in the neuroendocrine regulation of appetite, energy balance and glucose homeostasis.

The project “Hypothalamic T3” was initiated to investigate the potential of hypothalamic thyroid hormone in the neuroendocrine regulation of appetite, energy balance and glucose homeostasis. A role for thyroid hormone in the regulation of energy expenditure has long been known with overt clinical consequences of energy imbalance in patients with thyroid dysfunction. Until recently the effects of thyroid hormone on metabolism were thought to be mediated by the action of T3 directly in peripheral tissues, but new evidence clearly points to another facet of thyroid hormone action – one of action in the hypothalamus to regulate appetite, energy balance and glucose metabolism. However, which homeostatic mechnisms thyroid hormone triggers in the brain is largely unknown. The aim of this project was to identify components of T3 action on appetite and energy balance regulatory mechanisms the hypothalamus. For more information, see attached PDF

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Obesity is a global epidemic. The number of people who are obese or overweight increases annually. Being obese or overweight significantly increases the risk of co-morbidities that are currently amongst the major health problems of modern times, including diabetes and cardiovascular disease, collectively known as the metabolic syndrome. Currently 2-7% of European healthcare budgets are consumed addressing health problems arising from excess body weight, and this is predicted to increase. Body weight regulation is complex. In order to find successful therapeutic interventions it is essential that we understand the molecular basis and mechanisms of appetite and energy balance regulation. For decades thyroid hormone deficiency has been known to cause obesity. It has been assumed that the principal cause of obesity by hypothyroidism is reduced energy expenditure in peripheral tissues. But there is now compelling evidence that thyroid hormone has a direct role in regulating neural mechanisms involved appetite and energy expenditure. The objectives of this project are 1. To show that T3 chronically released in the hypothalamus of the rat causes increased food intake, body weight with potential to develop into metabolic syndrome. 2. To identify thyroid hormone-regulated genes involved in hypothalamic control of appetite and energy balance. These objectives will be met by using state-of-the-art approaches including brain implant technology and microarray analysis of hypothalamic gene expression. The work will be carried out at the University of Aberdeen Rowett Institute of Health and Nutrition, an institute with a wealth of experience in nutrition research. The project is expected to provide significant new information on involvement and mechanism of thyroid hormone in appetite and energy balance, and to contribute to priorities identified in EU work programmes of FP5, FP6 and the current FP7 work programme for Health.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз